novel combination in mm: bcma car t-cells with a gamma secretase inhibitor
Published 4 years ago • 128 plays • Length 3:47
Download video MP4
Download video MP3
Similar videos
-
3:17
anti-bcma car t-cells for mm: durable clinical responses with ide-cel (formerly bb2121)
-
1:27
early results of phe885, a novel bcma-directed car-t therapy for the treatment of r/r mm
-
2:23
exciting results from cartitude-1: anti-bcma car-t for mm
-
2:23
prognostic value of alc following bcma car t-cell therapy in multiple myeloma
-
3:31
phe885, a novel bcma-directed car-t therapy for patients with r/r multiple myeloma
-
6:34
bcma-cd38 bispecific car-t cells in r/r mm
-
2:19
novel avenues for mm treatment: car t-cells, venetoclax, induction & mrd
-
1:59
treating r/r cll: the value of btkis and venetoclax
-
1:53
phe885, a t-charge manufactured bcma-directed car-t therapy in r/r myeloma
-
1:53
the detection and management of mnts following bcma-directed car-t therapy
-
2:27
bms-986393, a novel anti-gprc5d car-t cell therapy, in multiple myeloma
-
2:16
the sequencing of novel therapies in myeloma (car-t, bispecifics, antibody-drug conjugates)
-
3:35
phase i/ii trial of p-bcma-101 car-t cell therapy in r/r myeloma
-
2:10
cb011: a novel genome-engineered bcma-specific car-t cell therapy
-
0:50
the practical challenges of using novel car t-cell agents
-
0:54
ucartcs1: a novel allogeneic car-t therapy for myeloma
-
1:01
an update on the phase i trial of bms-986393, a novel gprc5d-targeted car-t, in r/r myeloma
-
1:59
novel car-t constructs being investigated for the treatment of all
-
0:58
novel car-t constructs emerging in multiple myeloma for patients who experience loss of bcma
Clip.africa.com - Privacy-policy